Cellomatics Biosciences Wins Queen’s Award For EnterpriseGemma Cann2024-11-28T14:56:21+00:00April 21st, 2022|BioCity Nottingham, News|
Platelet Services Appoints Senior Research Scientist To Support GrowthGemma Cann2024-11-28T14:56:55+00:00March 30th, 2022|BioCity Nottingham, News|
From Kitchen Ingredient To Saving Lives – Phenotypeca Pioneers Improved Use Of Baker’s YeastGemma Cann2024-11-28T15:13:44+00:00March 10th, 2022|BioCity Nottingham, News|
Winners Announced For Medilink Midlands Business Awards 2022Gemma Cann2024-11-28T15:16:09+00:00February 15th, 2022|BioCity Nottingham, MediCity Nottingham, News|
Nottingham CRO Bolsters Team With Appointment Of Senior Molecular BiologistGemma Cann2024-11-28T15:29:53+00:00February 14th, 2022|BioCity Nottingham, MediCity Nottingham, News|
Phenotypeca Announces Commencement Of Lab 4.0 ProjectGemma Cann2024-11-28T15:16:33+00:00February 4th, 2022|BioCity Nottingham, News|
Myconoes Wins £21k Innovate UK GrantGemma Cann2022-06-30T11:43:27+01:00February 2nd, 2022|BioCity Nottingham, News|
Sygnature Discovery Appoints Dr Charles Woler As ChairmanGemma Cann2024-11-28T15:17:03+00:00January 14th, 2022|BioCity Nottingham, News|
Gateley Acquires IP Specialists Adamson JonesGemma Cann2022-06-30T11:45:01+01:00January 13th, 2022|BioCity Nottingham, News|
Finalists Announced For The Medilink Midlands Business Awards 2022Gemma Cann2024-11-28T15:30:27+00:00December 15th, 2021|BioCity Nottingham, MediCity Nottingham, News|
